| 神经元特异性烯醇化酶在弥漫大B细胞淋巴瘤缓解患者血清中的表达及其意义 |
| |
| 引用本文： | 陈连香,肖镇,黄彬涛,王威. 神经元特异性烯醇化酶在弥漫大B细胞淋巴瘤缓解患者血清中的表达及其意义[J]. 白血病．淋巴瘤, 2014, 23(2): 103-106 |
| |
| 作者姓名： | 陈连香 肖镇 黄彬涛 王威 |
| |
| 作者单位： | 陈连香(内蒙古医科大学附属医院血液内科, 呼和浩特,010050)；肖镇(内蒙古医科大学附属医院血液内科, 呼和浩特,010050)；黄彬涛(内蒙古医科大学附属医院血液内科, 呼和浩特,010050)； 王威 (内蒙古自治区人民医院急诊外科)； |
| |
| 摘 要： | 目的 探讨神经元特异性烯醇化酶（NSE）在弥漫大B细胞淋巴瘤（DLBCL）缓解患者中的表达情况及其与预后的关系.方法 采用电化学发光法检测40例初次诊断后经6～8个疗程化疗达到缓解的DLBCL患者及20例对照组血清NSE水平,分析NSE表达与预后的关系.结果 DLBCL缓解患者NSE表达阳性率为50％（20/40）,对照组NSE表达阳性率为10％（2/10）,两组间比较差异有统计学意义（P＜ 0.001）；NSE表达阴性及NSE表达阳性DLBCL缓解患者2年无进展生存（PFS）率分别为20.9％和6.6％,两组间差异有统计学意义（P＜0.01）；NSE为预后不良独立危险因素.结论 NSE是DLBCL缓解患者的独立不良预后指标,对判断缓解DLBCL的预后有重要意义.
|
| 关 键 词： | 淋巴瘤,大B细胞,弥漫型 神经元特异性烯醇化酶 血清 |
Expression of neuron specific enolase in serum of remission patients with diffuse large B-cell lymphoma and its significance |
| |
| Chen Lianxiang,Xiao Zhen,Huang Bintao,Wang Wei. Expression of neuron specific enolase in serum of remission patients with diffuse large B-cell lymphoma and its significance[J]. Journal of Leukemia & Lymphoma, 2014, 23(2): 103-106 |
| |
| Authors: | Chen Lianxiang Xiao Zhen Huang Bintao Wang Wei |
| |
| Affiliation: | . Department of Medical Hematology, Affiliated Hospital of Inner Mongolia Medical College, Hohhot 010050, China |
| |
| Abstract: | Objective To examine the expression of neuron-specific enolase （NSE） in patients with remission diffuse large B-cell lymphoma （DLBCL）, and to explone its prognostic value. Methods Serum NSE values were mesured by electmchemilumineseence immunoassay in 20 health donors and 40 DLBCL patients reached remission after 6-8 cycles of chemotherapy after initial diagnosis. Results Positive expressions rate of NSE in remission DLBCL patients was 50 %, and was 10 % in health donors （P 〈 0.01）. In remission DLBCL patients, there was significant difference in the 2-year PFS rate between in NSE-positive group and negative group （6.6 % vs 20.9% , P 〈 0.001）. Serum NSE was an independent poor prognostic factor in remission DLBCL patients. Conclusion Serum NSE expressions is an independent poor prognostic factor of remission DLBCL and has significant clinical value. |
| |
| Keywords: | Lymphoma, large B-cell, diffuse Neuron specific enolase Serum |
| 本文献已被 维普 等数据库收录！ |
|
